✦ LIBER ✦

Erratum to Puricelli et al., “Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells”. Int J Cancer 2002;100:642-53

Publisher: John Wiley and Sons
Year: 2005
Tongue: French
Weight: 23 KB
Volume: 117
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.21414

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The original article to which this Erratum refers was published in International Journal of Cancer (2002) 100(6) 642–653 DOI: 10.1002/ijc.10533

📜 SIMILAR VOLUMES

Heregulin inhibits proliferation via ERK

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells

✍ Lydia Puricelli; Cecilia J. Proiettii; Leticia Labriola; Mariana Salatino; María 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 530 KB

Heregulin (HRG) and type I receptor tyrosine kinase (RTK) expression was investigated in the highly invasive and metastatic LM3 cell line, our previously described model of metastasis for mammary cancer (Bal de Kier Joffe et al. [1986] Invasion Metastasis 6:302-12; Urtreger et al. [1997] Int J Oncol